Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1391438 | Chemistry & Biology | 2011 | 11 Pages |
SummaryGliotoxin, a redox-active metabolite, is produced by the opportunistic fungal pathogen Aspergillus fumigatus, and its biosynthesis is directed by the gli gene cluster. Knowledge of the biosynthetic pathway to gliotoxin, which contains a disulfide bridge of unknown origin, is limited, although L-Phe and L-Ser are known biosynthetic precursors. Deletion of gliG from the gli cluster, herein functionally confirmed as a glutathione S-transferase, results in abrogation of gliotoxin biosynthesis and accumulation of 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione. This putative shunt metabolite from the gliotoxin biosynthetic pathway contains an intriguing hydroxyl group at C-6, consistent with a gliotoxin biosynthetic pathway involving thiolation via addition of the glutathione thiol group to a reactive acyl imine intermediate. Complementation of gliG restored gliotoxin production and, unlike gliT, gliG was found not to be involved in fungal self-protection against gliotoxin.
► Deletion of Aspergillus fumigatus gliG abolishes gliotoxin biosynthesis ► An acyl imine intermediate is predicted to occur during gliotoxin biosynthesis ► Glutathione appears to be the actual thiol source in gliotoxin biosynthesis ► GliG, a glutathione S-transferase, is not involved in gliotoxin resistance